Barron’s Magazine – February 6, 2023 issue:

Pfizer Is Moving Beyond Covid. Why Its Stock Is a Buy.

With its packed pipeline, growing R&D spending, and potential deals and share buybacks, there’s more to the drugmaker than the market realizes.

These REITs Could Gain in a Housing Slump

Real estate investment trusts that own apartments and single-family houses could see gains as the rental market stays strong. How to invest.

This Industrial-Gas Giant Is Investing Big in Hydrogen. It’s Time to Buy the Stock.

Linde has been making major investments in hydrogen deals, and is increasingly moving into low- or no-carbon production methods. Earnings could take a few years to develop, but now may be a buying opportunity.

Magazine Archive - January 09, 2023 - Barron's

Barron’s Magazine – January 23, 2023 Issue:

Our Roundtable Pros Scoured the Market. Here Are 26 of Their Top Stock Picks.

Shares of companies with strong fundamentals are poised to shine this year, no matter the economic backdrop. Toyota and Warner Bros. fit the bill.

When a Target-Date Fund Just Doesn’t Cut It for Retirement Investors

Target-date funds have become a mainstay of America’s retirement plans. While they have their benefits, investors may be better off with a more nuanced approach, especially as they near retirement.